Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis
Clinical trial NCT06860542 · RECRUITING
Trial details
- NCT number
- NCT06860542
- Sponsor
- AHS Cancer Control Alberta
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-10
- Primary completion
- 2029-12-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.